The role of prostaglandin E2 in stroke-reperfusion injury

Yakugaku Zasshi

Volumn 133, Issue 9, 2013, Pages 947-954

  Ikeda Matsuo, Yuri ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Brain ischemia; Cyclooxygenase 2; EP3 receptor; Microsomal prostaglandin E synthase; Stroke reperfusion injury

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; ISOMERASE; PROSTAGLANDIN E SYNTHASE; PTGS2 PROTEIN, MOUSE;

ANIMAL MODEL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; EXCITOTOXICITY; MOUSE; NONHUMAN; REPERFUSION INJURY; REVIEW; METABOLISM; PHYSIOLOGY;

CYCLOOXYGENASE 2; DINOPROSTONE; INTRAMOLECULAR OXIDOREDUCTASES; REPERFUSION INJURY; STROKE;

EID: 84883359577     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.13-00171     Document Type: Review

References (17)

1. Amantea D., Nappi G., Bernardi G., Bagetta G., Corasaniti M. T., FEBS J., 276, 13-26 (2009).
2. Iadecola C., Niwa K., Nogawa S., Zhao X., NagayamaM., Araki E., Morham S., RossM. E., Proc. Natl. Acad. Sci. USA, 98, 1294-1299 (2001).
3. Nogawa S., Zhang F., Ross M. E., Iadecola C., J. Neurosci., 17, 2746-2755 (1997).
4. Takadera T., Shiraishi Y., Ohyashiki T., Neurochem. Int., 45, 713-719 (2004).
5. Cazevieille C., Muller A., Meynier F., Dutrait N., Bonne C., Neurochem. Int., 24, 395-398 (1994).
6. Cheung R. T., Pei Z., Feng Z. H., Zou L. Y., Neurosci. Lett., 330, 57-60 (2002).
7. Samuelsson B., Morgenstern R., Jakobsson P. J., Pharmacol. Rev., 59, 207-224 (2007).
8. Ikeda-Matsuo Y., Ikegaya Y., Matsuki N., Uematsu S., Akira S., Sasaki Y., J. Neurochem., 94, 1546-1558 (2005).
9. Ikeda-Matsuo Y., Ota A., Fukada T., Uematsu S., Akira S., Sasaki Y., Proc. Natl. Acad. Sci. USA, 103, 11790-11795 (2006).
10. Murakami M., Naraba H., Tanioka T., Semmyo N., Nakatani Y., Kojima F., Ikeda T., Fueki M., Ueno A., Oh-ishi S., Kudo I., J. Biol. Chem., 275, 32783-32792 (2000).
11. Ikeda-Matsuo Y., Hirayama Y., Ota A., Uematsu S., Akira S., Sasaki Y., Br. J. Pharmacol., 159, 1174-1186 (2010).
12. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K. A., Kunz A., Cho S., Orio M., Iadecola C., Nat. Med., 12, 225-229 (2006).
13. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R. M., Andreasson K., J. Neurosci., 24, 257-268 (2004).
14. Ikeda-Matsuo Y., Tanji H., Ota A., Hirayama Y., Uematsu S., Akira S., Sasaki Y., Br. J. Pharmacol., 160, 847-859 (2010).
15. Ikeda-Matsuo Y., Tanji H., Narumiya S., Sasaki Y., J. Neuroimmunol., 238, 34-43 (2011).
16. Akitake Y., Nakatani Y., Kamei D., Hosokawa M., Akatsu H., Uematsu S., Akira S., Kudo I., Hara S., Takahashi M., J. Neurosci. Res., 91, 909-919 (2013).
17. Takemiya T., Matsumura K., Sugiura H., Maehara M., Yasuda S., Uematsu S., Akira S., Yamagata K., J. Neurosci. Res., 88, 381-390 (2010).